Patients with MEN-1 are more insulin-resistant than their non-affected relatives
- 30 November 2005
- journal article
- Published by Elsevier BV in European Journal of Internal Medicine
- Vol. 16 (7), 507-509
- https://doi.org/10.1016/j.ejim.2005.09.008
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- A central role for JNK in obesity and insulin resistanceNature, 2002
- Studies of the Dysglycemic Peptide, Pancreastatin, Using a Human Forearm ModelAnnals of the New York Academy of Sciences, 2002
- Menin uncouples Elk-1, JunD and c-Jun phosphorylation from MAP kinase activationOncogene, 2002
- Changes in the concentration and composition of plasma lipoproteins during the acute phase responseCurrent Opinion in Clinical Nutrition and Metabolic Care, 2002
- Pancreastatin modulates insulin signaling in rat adipocytes: mechanisms of cross-talk.Diabetes, 2000
- The c-Jun NH2-terminal Kinase Promotes Insulin Resistance during Association with Insulin Receptor Substrate-1 and Phosphorylation of Ser307Published by Elsevier BV ,2000
- Measurements of chromogranin A, chromogranin B (secretogranin I), chromogranin C (secretogranin II) and pancreastatin in plasma and urine from patients with carcinoid tumours and endocrine pancreatic tumoursJournal of Endocrinology, 1995
- Insulin secretion, insulin sensitivity and hepatic insulin extraction in primary hyperparathyroidism before and after surgeryClinical Endocrinology, 1992